Orocam Transmucosal Oral Spray is a drug owned by ZOETIS INC. It is protected by 3 US drug patents filed from 2016 to 2030. Out of these, 1 patent is active and 2 patents have expired. Details of Orocam Transmucosal Oral Spray’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6110486 | 12 Apr, 2016 | Expired |
Exclusivity Information
Orocam Transmucosal Oral Spray holds 1 exclusivity out of which 1 has expired. Details of Orocam Transmucosal Oral Spray's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Nov 02, 2015 |
About Orocam Transmucosal Oral Spray
Orocam Transmucosal Oral Spray is a drug
owned by ZOETIS INC.
Orocam Transmucosal Oral Spray uses
Meloxicam as the active
ingredient.
Active Ingredient:
Orocam Transmucosal Oral Spray uses
Meloxicam as the active ingredient.
Check out other Drugs and Companies using
Meloxicam ingredient.